M. Lamba

A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

W.C. Ports, Sairah Khan, Shu-Ping Lan et al. · British Journal of Dermatology · 2013 · 200 citations · Full text

Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma

Víctor Moreno, María Vieito, Tatiana Hernández‐Guerrero et al. · Annals of Oncology · 2020 · 66 citations · Full text

Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients

Flavio Vincenti, Hélio Tedesco‐Silva, Stéphan Busque et al. · American Journal of Transplantation · 2015 · 54 citations

Urology, Transplantation, Kidney Transplant +8

Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib

M. Lamba, MM Hutmacher, D.E. Furst et al. · Clinical Pharmacology & Therapeutics · 2016 · 38 citations · Full text

Salivary Gland Lymphoproliferative Disorders: A Canadian Tertiary Center Experience

Aleksandra Paliga, James Farmer, Isabelle Bence‐Bruckler et al. · Head and Neck Pathology · 2013 · 17 citations · Full text

Histopathology, Pathology, Lymphatic Disease +2